天然痘治療法の世界市場予測・分析2019-2023

【英語タイトル】Smallpox Treatment Market by Product and Geography - Global Forecast and Analysis 2019-2023

Technavioが出版した調査資料(IRTNTR32051)・商品コード:IRTNTR32051
・発行会社(調査会社):Technavio
・発行日:2019年9月28日
・ページ数:129
・レポート言語:英語
・レポート形式:PDF
・納品方法:Eメール(受注後24時間以内)
・調査対象地域:グローバル
・産業分野:医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD2,500 ⇒換算¥280,000見積依頼/購入/質問フォーム
Five User(5名様閲覧用)USD3,000 ⇒換算¥336,000見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD4,000 ⇒換算¥448,000見積依頼/購入/質問フォーム
販売価格オプションの説明
※お支払金額:換算金額(日本円)+消費税
※納期:即日〜2営業日(3日以上かかる場合は別途表記又はご連絡)
※お支払方法:納品日+5日以内に請求書を発行・郵送(請求書発行日より2ヶ月以内に銀行振込、振込先:三菱UFJ銀行/H&Iグローバルリサーチ株式会社、支払期限と方法は調整可能)
Technavio社の本調査レポートでは、天然痘治療法の世界市場について調べ、天然痘治療法の市場状況、市場規模、市場予測、市場環境、顧客状況、市場動向、関連企業情報などをまとめました。また、天然痘治療法の市場規模をセグメンテーション別(製品別(薬物、ワクチン)、)と地域別(グローバル)に分けて算出しました。Technavio社は天然痘治療法の世界市場規模が2019-2023期間中に年平均2%成長すると予測しています。
・サマリー
・レポートの範囲
・天然痘治療法の市場状況
・天然痘治療法の市場規模
・天然痘治療法の市場予測
・天然痘治療法の世界環境:ファイブフォース分析
・市場セグメンテーション:製品別(薬物、ワクチン)
・天然痘治療法の顧客状況
・主要地域別市場規模:グローバル
・意思決定フレームワーク
・市場動向・成長要因・課題
・関連企業状況・企業分析
 ...
【レポートの概要】

Global Smallpox Treatment Market: About this market

Technavio’s smallpox treatment market analysis considers sales from both drugs and vaccines products. Our analysis also considers the sales of smallpox treatment in Asia, Europe, North America, and ROW. In 2018, the smallpox treatment drugs segment had a significant market share, and this trend is expected to continue over the forecast period. Factors such as growing support from healthcare and regulatory bodies will play a significant role in the smallpox treatment drugs segment to maintain its market position. Also, our global smallpox treatment market report looks at factors such as increasing stockpiling of smallpox therapeutics, increasing drug approvals, and increasing contract manufacturing practices. However, complexities involved in vaccine storage and transportation, side-effects associated with smallpox vaccines, and stringent regulatory environment may hamper the growth of the smallpox treatment industry over the forecast period.

Global Smallpox Treatment Market: Overview

Increasing contract manufacturing practices

Contract manufacturing organizations are hired for the developing and manufacturing vaccines. These organizations provide the necessary solutions and technologies to their clients to produce vaccines and sustain their stockpiling to prepare for a future epidemic. The global smallpox treatment market has been witnessing an increase in contract manufacturing practices, wherein the government is licensing manufacturers to develop smallpox vaccines. Apart from offering cost-saving benefits, vaccine contracting services also help in saving operation time associated with the development and manufacturing of vaccines. This growing popularity of contract manufacturing practices will lead to the expansion of the global smallpox treatment market at a CAGR of almost 2% during the forecast period.

Expedited approvals

The global smallpox treatment market is expected to benefit from expedited approvals for vaccines and other drugs. The major vendors in the global smallpox treatment market are engaged in conducting research trials for their novel smallpox therapeutics, for which they have received priority review to facilitate the development and approval process. The drug approval process for novel drug therapeutics is a tedious process, and each drug undergoes a thoroughly detailed review by the US FDA before it is launched in the market. US regulatory authorities are also granting priority review status for smallpox therapeutics to cater to the increasing need for stockpiling in the US. For instance, the US FDA has granted priority review status and accepted the BLA for the liquid-frozen MVA-BN smallpox vaccine being developed by Bavarian Nordic. This will help in facilitating the review process for the future BLA, thereby expediting its approval. This development is expected to have a positive impact on the overall market growth.

For the detailed list of factors that will drive the global smallpox treatment market during the forecast period 2019-2023, click here.

Competitive Landscape

With the presence of a few major players, the global smallpox treatment market is concentrated. Technavio’s robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of few leading smallpox treatment manufacturers, that include Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., and SIGA Technologies Inc.

Also, the smallpox treatment market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage on all forthcoming growth opportunities.

【レポートの目次】

PART 01: EXECUTIVE SUMMARY

PART 02: SCOPE OF THE REPORT

2.1 Preface

2.2 Preface

2.3 Currency conversion rates for US$

PART 03: MARKET LANDSCAPE

Market ecosystem

Market characteristics

Market segmentation analysis

PART 04: MARKET SIZING

Market definition

Market sizing 2018

Market size and forecast 2018-2023

PART 05: FIVE FORCES ANALYSIS

Bargaining power of buyers

Bargaining power of suppliers

Threat of new entrants

Threat of substitutes

Threat of rivalry

Market condition

PART 06: MARKET SEGMENTATION BY PRODUCT

Market segmentation by product

Comparison by product

Drugs – Market size and forecast 2018-2023

Vaccines – Market size and forecast 2018-2023

Market opportunity by product

PART 07: CUSTOMER LANDSCAPE

PART 08: GEOGRAPHIC LANDSCAPE

Geographic segmentation

Geographic comparison

North America – Market size and forecast 2018-2023

Europe – Market size and forecast 2018-2023

Asia – Market size and forecast 2018-2023

ROW – Market size and forecast 2018-2023

Key leading countries

Market opportunity

PART 09: DRIVERS AND CHALLENGES

Market drivers

Market challenges

PART 10: TRENDS

Increasing efforts by vendors

Growing threat of bioterrorism

Expedited approvals

PART 11: VENDOR LANDSCAPE

Overview

Landscape disruption

Competitive scenario

PART 12: VENDOR ANALYSIS

Vendors covered

Vendor classification

Market positioning of vendors

Bavarian Nordic AS

Emergent BioSolutions Inc.

Pfizer Inc.

SIGA Technologies Inc.

PART 13: APPENDIX

Research methodology

List of abbreviations

Definition of market positioning of vendors

PART 14: EXPLORE TECHNAVIO

Exhibit 01: Vendors: Key offerings

Exhibit 02: Global pharmaceuticals market

Exhibit 03: Segments of global pharmaceuticals market

Exhibit 04: Market characteristics

Exhibit 05: Market characteristics analysis

Exhibit 06: Market segments

Exhibit 07: Market definition – Inclusions and exclusions checklist

Exhibit 08: Market size 2018

Exhibit 09: Global market: Size and forecast 2018-2023 ($ millions)

Exhibit 10: Global market: Year-over-year growth 2019-2023 (%)

Exhibit 11: Five forces analysis 2018

Exhibit 12: Five forces analysis 2023

Exhibit 13: Bargaining power of buyers

Exhibit 14: Bargaining power of suppliers

Exhibit 15: Threat of new entrants

Exhibit 16: Threat of substitutes

Exhibit 17: Threat of rivalry

Exhibit 18: Market condition – Five forces 2018

Exhibit 19: Product – Market share 2018-2023 (%)

Exhibit 20: Comparison by product

Exhibit 21: Drugs – Market size and forecast 2018-2023 ($ millions)

Exhibit 22: Drugs – Year-over-year growth 2019-2023 (%)

Exhibit 23: Vaccines – Market size and forecast 2018-2023 ($ millions)

Exhibit 24: Vaccines – Year-over-year growth 2019-2023 (%)

Exhibit 25: Market opportunity by product

Exhibit 26: Customer landscape

Exhibit 27: Customer landscape analysis

Exhibit 28: Market share by geography 2018-2023 (%)

Exhibit 29: Geographic comparison

Exhibit 30: North America – Market size and forecast 2018-2023 ($ millions)

Exhibit 31: North America – Year-over-year growth 2019-2023 (%)

Exhibit 32: Top 3 countries in North America

Exhibit 33: Europe – Market size and forecast 2018-2023 ($ millions)

Exhibit 34: Europe – Year-over-year growth 2019-2023 (%)

Exhibit 35: Top 3 countries in Europe

Exhibit 36: Asia – Market size and forecast 2018-2023 ($ millions)

Exhibit 37: Asia – Year-over-year growth 2019-2023 (%)

Exhibit 38: Top 3 countries in Asia

Exhibit 39: ROW – Market size and forecast 2018-2023 ($ millions)

Exhibit 40: ROW – Year-over-year growth 2019-2023 (%)

Exhibit 41: Top 3 countries in ROW

Exhibit 42: Key leading countries

Exhibit 43: Market opportunity

Exhibit 44: Decision framework

Exhibit 45: Impact of drivers and challenges

Exhibit 46: Vendor landscape

Exhibit 47: Landscape disruption

Exhibit 48: Vendor landscape analysis

Exhibit 49: Vendors covered

Exhibit 50: Vendor classification

Exhibit 51: Market positioning of vendors

Exhibit 52: Bavarian Nordic AS – Vendor overview

Exhibit 53: Bavarian Nordic AS – Business segments

Exhibit 54: Bavarian Nordic AS – Organizational developments

Exhibit 55: Bavarian Nordic AS – Geographic focus

Exhibit 56: Bavarian Nordic AS – Key offerings

Exhibit 57: Emergent BioSolutions Inc. – Vendor overview

Exhibit 58: Emergent BioSolutions Inc. – Business segments

Exhibit 59: Emergent BioSolutions Inc. – Organizational developments

Exhibit 60: Emergent BioSolutions Inc. – Key offerings

Exhibit 61: Pfizer Inc. – Vendor overview

Exhibit 62: Pfizer Inc. – Business segments

Exhibit 63: Pfizer Inc. – Organizational developments

Exhibit 64: Pfizer Inc. – Geographic focus

Exhibit 65: Pfizer Inc. – Segment focus

Exhibit 66: Pfizer Inc. – Key offerings

Exhibit 67: SIGA Technologies Inc. – Vendor overview

Exhibit 68: SIGA Technologies Inc. – Business segments

Exhibit 69: SIGA Technologies Inc. – Organizational developments

Exhibit 70: SIGA Technologies Inc. – Key offerings

Exhibit 71: Validation techniques employed for market sizing

Exhibit 72: List of abbreviations

Exhibit 73: Definition of market positioning of vendors



【掲載企業】

Bavarian Nordic AS, Emergent BioSolutions Inc., Pfizer Inc., and SIGA Technologies Inc.

★調査レポート[天然痘治療法の世界市場予測・分析2019-2023] (コード:IRTNTR32051)販売に関する免責事項を必ずご確認ください。
★調査レポート[天然痘治療法の世界市場予測・分析2019-2023]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆